Introduction
Arterial hypertension is known as a major risk factor for several ocular and systemic diseases. Despite new and efficient antihypertensive drugs, hypertension is still associated with significant morbidity and mortality, mainly due to stroke, renal failure and myocardial infarction. 1 In the care of hypertensive patients, fundus alterations have long been considered to give stable and easily detectable information about the vascular status in less accessible organs. 2 In the eye, arterial hypertension is considered to be a major systemic risk factor for retinal artery and vein occlusion. 3, 4 Fluorescein angio-graphy is an established method not only to assess, but also to quantify microvascular changes in a variety of retinal diseases. 5, 6 In patients with mild to moderate hypertension, an enlargement of the perifoveal intercapillary areas (PIA) and a reduced capillary blood velocity (CBV) was found. 7 However, for the severe stages of hypertensive retinopathy, the perifoveal microcirculation has not yet been quantified. Theoretically, a further decline in capillary density and capillary flow velocity would be expected.
Therefore we evaluated the perifoveal microcirculation in patients with mild to severe hypertensive retinopathy. Patients were staged according to the classification of Neubauer, 8 a modification of the classification of Keith and Wagener, that distinguishes between fundus hypertonicus (stages I-II = mild) and hypertensive retinopathy (stages III-IV = severe). By means of fluorescein angiography and digital image analysis, we measured PIA, CBV, and
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Materials and methods
Study population
We consecutively examined 143 patients (M:F = 65:78) with arterial hypertension in the outpatient department of the University Eye Hospital Aachen, Germany. The patients were presented by the Department of Medicine of the University Hospital Aachen for the staging of hypertensive retinopathy. Each patient had a well-established history of arterial hypertension for at least 3 months. Stage IV patients were presented after initial stabilisation of acerbated arterial hypertension. All patients were under antihypertensive treatment with one (n = 49) or a combination (n = 94) of the following drugs: calcium channel blockers, beta-blockers, ACEinhibitors, alpha-antagonists, and diuretics. Diagnosis was established by complete clinical and laboratory investigations. Exclusion criteria were any form of secondary hypertension, cardiovascular disease other than arterial hypertension, and collagen diseases, acute infections at the time of examination and fundus alterations that did not result from arterial hypertension. In addition, patients with allergic disease or history of sensitivity to fluorescein were excluded. All participants gave written informed consent for all procedures. The protocol was approved by the ethics review board of the Technical University of Aachen and followed the tenets of the Helsinki declaration.
Protocol
All patients underwent a complete ophthalmological examination including best corrected visual acuity, slit-lamp biomicroscopy and Goldmann applanation tonometry. Using fundus photography the hypertensive fundus alterations were classified by two experienced ophthalmologists in a masked fashion into four groups according to Neubauer 8 (see Figure 1 / Table 1 ).
Subsequently, fluorescein angiography was performed in one randomly selected eye of each patient with a scanning laser ophthalmoscope. Before angiography, blood pressure (BP) and heart rate was recorded by automatic sphygomanometry (Criticon 845 XT) in the sitting position after 5 min of rest. Stage IV patients were examined within 4 days after stabilisation. Using offline digital image analysis PIA, CBV, and FAZ were quantified by a masked examiner.
Methods
Fluorescein angiography was performed with a scanning laser ophthalmoscope (Rodenstock SLO-101). Digital image analysis was performed using the Kontron lbas II System. Both techniques have been extensively described elsewhere. 10 The PIA describes the capillary density of the perifoveal network. The borders of 100 intercapillary areas were interactively marked by drawing the surrounding capillaries with a cursor. The area of interest was defined by a circle of 5°placed concentric around the fovea, whereas the areas to measure should be distributed equally around the fovea.
For measurement of the FAZ, the inner capillary arcade surrounding the fovea was marked interactively. CBV was determined by measuring the movement of hypofluorescent gaps through capillaries of the perimacular region. These gaps are presumed to be rouleaux formations of red blood cells.
11 CBV was calculated from 80 up to 100 single flow velocity measurements performed in 15 different capillaries. All morphologic and dynamic data were corrected for refractive error according to Littmann.
12
Statistical analysis
The Kolmogorov-Smirnov test was used to determine normal distribution. The Student's t-test was used to assess the significance of the results. The level of significance was corrected according to Holm 13 and was set to less than 0.05. Normal distributed group data is presented as mean ± standard deviation (× ± s.d.).
Results
Population characteristics
Out of the 143 patients, 49 presented stage I and 72 stage II of hypertensive retinopathy. The more severe stages III and IV were found in 16 and six patients respectively.
Characteristics of the study population are presented in Table 2 . Regarding age, patients of stage II were significantly older than patients of stage I (51 ± 10 years vs 41 ± 15 years; P Ͻ 0.001), the other groups did not differ significantly from each other. Mean systolic BP was significantly higher in stage III compared with stage I (154 ± 20 mm Hg vs 139 ± 18 mm Hg; P Ͻ 0.01) and in stage IV compared with stage I and stage II (184 ± 50 mm Hg vs 139 ± 18 mm Hg; P Ͻ 0.0001 resp. 147 ± 21 mm Hg; P Ͻ 0.001). No significant difference was found between the different stages with respect to diastolic BP, heart rate and duration of the disease.
Angiographic data
PIA, its coefficient of variation (CV (PIA)) and the FAZ, are parameters that describe the morphology of the perifoveal capillary network. There is an inverse relationship between PIA and retinal capillary density. Compared with normal values (3872 ± , P Ͻ 0.0001; and stage IV = 6958 ± 1147 m 2 , P Ͻ 0.0001). When comparing the different stages with each other, we saw a significant increase of PIA from stage I and II to stage III and IV (P Ͻ 0.0001), but no difference between stages I and II or between stages III and IV (see Table  3 / Figure 2) .
The CV (PIA), indicating the level of homogeneity of the perifoveal capillary network, had increased significantly compared with normal values (35 ± 9%) 9 in stage II (42 ± 15%; P Ͻ 0.002), III (45 ± 22%; p Ͻ 0.007) and IV (53 ± 9%; P Ͻ 0.0001). Furthermore, stage IV showed a significantly increased variation coefficient with regard to stage I (53 ± 9% vs 37 ± 12%; P Ͻ 0.004).
CBV was reduced significantly in stage I (2.185 ± 0.277 mm/s, P Ͻ 0.0001), stage II (2.148 ± 0.255 mm/s, P Ͻ 0.0001), stage III (1.938 ± 0.176 mm/s, P Ͻ 0.0001) and stage IV (1.866 ± 0.048 mm/s, P Ͻ 0.0001) compared with normal values (2.887 ± 0.406 mm/s). The variation coefficient of CBV (CV (CBV)) did not differ significantly among the stages and when compared with normal values. 9 A significant decrease of CBV (P Ͻ 0.05) was seen between the stages I-II and stages III-IV,
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but neither between stage I and II nor between stage III and IV (see Table 3 / Figure 3) .
A tendency towards an enlargement of the FAZ was observed within the hypertensive patients. This finding however was not statistically significant.
Discussion
The systemic character and the resulting prognostic impact of hypertensive fundus changes have long been established. [14] [15] [16] Histopathologic findings indicating similar changes in cerebral, coronary, and renal vessels of patients with hypertensive retinopathy have underlined the importance of routine ophthalmoscopy. 17 Meanwhile, fluorescein angiography has become a widespread diagnostic method for studying retinal microcirculation in vivo. 6, 18, 19 Quantification of morphologic and haemodynamic parameters has become possible because of improved digital image acquisition and analysis. 20 In patients with mild to moderate hypertensive fundus changes, a significant reduction of PIA and CBV has already been demonstrated, 7 whereby the amount of reduction was found to be independent from the applied antihypertensive drugs. 18 In this study, a further reduction of capillary density and capillary blood velocity was observed in the more severe stages of hypertensive retinopathy. This data, revealing progressive microvascular damage, is supported by several clinical and experimental studies showing progressive capillary closure accompanied by an increased resistance and resulting decrease of perfusion in hypertensive humans [21] [22] [23] and various animal models. [24] [25] [26] [27] In animal models, capillary closure was found to be reversible within the first few weeks, but became irreversible due to structural changes of the vessel wall in the course of time, thus resulting in a permanently increased flow resistance. [24] [25] [26] [27] Even though we found a decrease of capillary den- Based on the ophthalmoscopically visible alterations, several classifications of hypertensive fundus changes have been proposed. [28] [29] [30] In clinical routine, the widespread classification of Keith and Wagener 31 has been a standard for grading fundus changes in patients with arterial hypertension for more than 60 years. Similar to the Neubauer classification used in this study, Keith and Wagener distinguish between four stages of hypertensive retinopathy. Contrary to Keith and Wagener, the Neubauer classification also differentiates between arteriosclerotic and hypertensive fundus changes. Furthermore, Neubauer further distinguishes between stages I-II and III-IV: stages I-II are named fundus hypertonicus, and stages II-IV hypertensive retinopathy. Early microvascular signs of hypertension, however, are known to be subject to observer error when assessed by conventional funduscopy. In addition, the difficulty in separating mild from moderate hypertensive fundus changes limits the practicability of these classifications, 2, 32 and the usefulness of ophthalmoscopy in mild to moderate hypertension has been questioned. 33 Some authorities even state that ophthalmoscopy is not a reliable diagnostic method for evaluating the severity of the disease, especially when practiced by a non-ophthalmologist. 34 Therefore, Dodson 35 proposed a simplified classification scheme which differentiated only between non-malignant and malignant hypertensive retinopathy. Neubauer also partially made allowance for that critical issue by distinguishing between fundus hypertonicus and hypertensive retinopathy.
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Taken together, the angiographic data revealed in our study, indicate that significant angiographic differences between mild and severe form of hyperten- Journal of Human Hypertension sive retinopathy exist, however, unlike in ophthalmoscopy, no differentiated segmentation into four stages is possible.
